Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dongin Pharmaceutical is a South Korean pharmaceutical company established in 1993 that focuses on the development, manufacture, and distribution of a diverse range of healthcare products. The company specializes in prescription (ETC) and over-the-counter (OTC) medications, with therapeutic strengths in respiratory, gastrointestinal, and musculoskeletal health. Operating out of a GMP-certified facility in Siheung, Dongin provides high-quality formulations including tablets, capsules, and topical treatments. In addition to its domestic commercial operations, the company offers contract manufacturing (CMO) services to partner organizations. Dongin Pharmaceutical remains dedicated to expanding its product portfolio through the introduction of effective generic medications and health supplements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DONGIN PHARMACEUTICAL.